Tea on the Hill: Navigating the Coming Congressional Currents
As the midterms approach, congressional Democrats are already deciding where they will look first. If they win the House in November, and they are planning as though they will, the next Congress will open with an oversight agenda that reaches beyond the administration to the companies whose conduct illustrates its policies. Those companies will come from across the economy.
This is the first in a series on what companies should expect from congressional investigations in 2027. Later installments will provide a sector-by-sector breakdown of the key issues likely to draw scrutiny, the points of exposure, and the strategic considerations unique to each industry. We begin with the investigative playbook itself: the strategy, the mechanics, and the decisions companies need to be making right now.
A New Investigative Playbook
Democrats have been explicit about their strategy. Rather than solely focusing on the Trump Administration, they intend to use private companies as a lens on administration policies and a platform for their message on affordability, competition, and consumer protection. A number of industries can expect to be under the congressional microscope in the coming year, and we will work through each of them here.
The timeline is aggressive. Democrats are targeting public hearings as early as spring 2027, and they are prepared to move quickly to subpoenas and contempt votes against companies they view as slow to cooperate. That threat is more credible than in past cycles. The Senate HELP Committee’s bipartisan vote to hold Steward Health Care’s CEO in civil and criminal contempt showed that contempt against a private-sector executive can draw support from both parties. Any criminal referral will still need the Trump Justice Department to act on it. That is less of a safeguard than it appears, because much of Congress’s leverage lies in the process itself, including the vote, the public record, and the reputational cost. Further, House Democrats are already coordinating with state attorneys general on parallel investigations, in a more explicit and broader alignment than in any prior cycle. Companies should assume that what they produce to Congress may reach state enforcers and prepare productions with that audience in mind.
Companies also cannot simply manage to one side of the aisle. Even if Democrats set the investigative agenda, relationships with Republicans and the administration will remain critical. Republicans will push back on what they see as Democratic overreach, and companies that sacrifice those relationships to placate the majority will be left without allies when they need them most. Navigating 2027 likely means strategically maintaining credible relationships on both sides of a divided Washington at once.
The clearest early signal is that a Democratic letter a company received in 2026 should be considered as a preview of a 2027 subpoena. Minority members cannot compel production today, but their requests show where they intend to look once they can. Companies that engage early and thoughtfully have a better chance of containing an inquiry before it escalates.
The playbook for navigating that environment exists, but it takes time to build. The companies best positioned for 2027 are making decisions today.
To receive the latest insights on US legal developments, subscribe to the Freshfields A Fresh Take Blog.
